Deep Vein Thrombosis
📧 Sign up to get email alerts when something new happens for Deep Vein Thrombosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2011-06-03Clinical Trial Update: Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)
A clinical trial update examining whether antepartum thromboprophylaxis is needed for pregnant women with one prior venous thromboembolism; …
-
CLINICAL_TRIALS trial_result · 2011-06-01Clinical Trial Update: Discharge ALERT: Quality Improvement Initiative [NA]
This completed study reports on a discharge-alert quality improvement initiative aimed at improving venous thromboembolism prophylaxis and p…
-
CLINICAL_TRIALS research · 2011-04-26Clinical Trial Update: Introducer Curving Technique for Tilt of Transfemoral Günther Tulip Inferior Vena Cava Filter [NA]
An update on a technique to address tilt of a Günther Tulip inferior vena cava filter during transfemoral placement in deep vein thrombosis.
-
CLINICAL_TRIALS trial_result · 2011-04-06Clinical Trial Update: Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT) [Phase 3]
A Phase 3 safety and efficacy trial of SR34006 for Deep Vein Thrombosis has completed. The summary does not detail trial results.
-
CLINICAL_TRIALS trial_result · 2011-04-06Clinical Trial Update: SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis [Phase 3]
A Phase 3 trial of SR34006 in patients who completed 6 months of treatment for symptomatic pulmonary embolism or deep vein thrombosis has co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-03-21Clinical Trial Update: Single Comprehensive Ultrasound to Rule Out DVT in High-risk Patients [NA]
A completed clinical trial evaluated whether a single comprehensive ultrasound can rule out deep vein thrombosis in high-risk patients.
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism [Phase 3]
A Phase 3 study comparing dabigatran etexilate with warfarin for six months of treatment in adults with acute symptomatic venous thromboembo…
-
CLINICAL_TRIALS trial_result · 2010-12-21Clinical Trial Update: Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis [Phase 4]
Phase 4 trial evaluating Innohep (tinzaparin) in elderly patients with impaired renal function treated for acute deep vein thrombosis; resul…
-
CLINICAL_TRIALS trial_result · 2010-12-17Clinical Trial Update: RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery [Phase 3]
Phase 3 trial comparing dabigatran etexilate 150 mg or 220 mg once daily with enoxaparin for prevention of venous thromboembolism after knee…
-
CLINICAL_TRIALS trial_result · 2010-12-14Clinical Trial Update: US-Doppler and Procoagulant Microparticles for the Diagnosis of Asymptomatic DVT in Advanced Cancer Patients With Poor Performance Status
A clinical trial evaluating ultrasound Doppler and procoagulant microparticles to diagnose asymptomatic deep vein thrombosis in advanced can…
-
CLINICAL_TRIALS trial_result · 2010-12-14Clinical Trial Update: Ultrasound (US)-Doppler for the Diagnosis of Asymptomatic Deep Vein Thrombosis (DVT) in Gynecologic Cancer Patients
The update describes a completed clinical trial evaluating ultrasound Doppler for diagnosing asymptomatic deep vein thrombosis in gynecologi…
-
FDA approval · 2010-10-19FDA Approved: PRADAXA — Original Application (Boehringer Ingelheim Pharmaceuticals Inc.)
The FDA approved Pradaxa (dabigatran etexilate mesylate) under an original NDA from Boehringer Ingelheim Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2010-08-10Clinical Trial Update: Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients
A completed trial evaluating Fragmin (dalteparin) for treatment of acute deep vein thrombosis in cancer patients, with or without pulmonary …
-
FDA approval · 2010-07-23FDA Approved: ENOXAPARIN SODIUM — Original Application (Sandoz Inc)
FDA approved Sandoz Inc's Original Application for Enoxaparin Sodium, a generic injectable anticoagulant. The approval authorizes marketing …
-
CLINICAL_TRIALS trial_result · 2010-07-12Clinical Trial Update: Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic Acid [Phase 4]
Phase 4 clinical trial update evaluating the pharmacodynamic interaction between warfarin and amoxicillin-clavulanic acid and its impact on …
-
FDA approval · 2010-06-30FDA Approved: HEPARIN SODIUM — Original Application (Sagent Pharmaceuticals)
FDA approved the original application for heparin sodium from Sagent Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients [Phase 3]
Phase 3 trial evaluating fondaparinux sodium (GSK576428) for acute deep vein thrombosis in Japanese patients has completed, with results pos…
-
FDA approval · 2010-03-26FDA Approved: ARIXTRA — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for ARIXTRA (fondaparinux sodium) submitted by Mylan Institutional LLC.
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study [Phase 2]
A Phase 2 trial evaluating apixaban for acute symptomatic deep vein thrombosis has completed. This Botticelli DVT study update summarizes th…
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery [Phase 2, Phase 3]
BMS-562247, studied in patients undergoing elective total knee replacement, completed its Phase 2/3 program for prevention of venous thrombo…
-
CLINICAL_TRIALS research · 2010-02-05Clinical Trial Update: Re-STOP DVT: Reload of High Dose Atorvastatin for Preventing Deep Vein Thrombosis in Statin Users [Phase 4]
This entry describes a Phase 4 trial investigating high-dose atorvastatin reloading to prevent deep vein thrombosis in statin users.
-
FDA approval · 2009-12-23FDA Approved: FRAGMIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Fragmin (dalteparin sodium) submitted by Pfizer Laboratories Div Pfizer Inc. The action indicate…
-
CLINICAL_TRIALS trial_result · 2009-12-15Clinical Trial Update: Comparison Study of CoaguChek XS PT and Laboratory Innovin PT by NTUH Lab Medicine
A completed clinical trial comparing CoaguChek XS PT to the Innovin PT thromboplastin reagent for prothrombin time testing in deep vein thro…
-
CLINICAL_TRIALS research · 2009-12-02Clinical Trial Update: Testing Strategies to Improving Warfarin Adherence [NA]
A completed clinical trial update describing strategies to improve adherence to warfarin therapy. The study involved patients with atrial fi…
-
CLINICAL_TRIALS research · 2009-11-02Clinical Trial Update: Antiplatelet Therapy Continuation in Spine Surgery - Its Effect on Postoperative Morbidity and Mortality
This document reports an update on a clinical trial evaluating whether continuing antiplatelet therapy after spine surgery affects postopera…